Colorectal Cancer Clinical Trials in Long Beach, CA

Colorectal Cancer Clinical Trials in Long Beach, CA

View the best 10 colorectal cancer medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Colorectal Cancer clinical trial.

Trials in Long Beach, California

Here are the top 10 medical studies for colorectal cancer in Long Beach, California

Image of Sarcoma Oncology in Santa Monica, United States.

HBI-2438

Epigenetic Modulator

Recruiting1 awardPhase 1
This trial tests HBI-2438, an oral drug for patients with advanced solid tumors having the KRAS G12C mutation. The drug aims to stop cancer growth by blocking the faulty gene. Related drugs, Adagrasib and Sotorasib, have shown effectiveness in treating similar conditions.
Image of Cancer Specialists of North Florida in Jacksonville, United States.

Sotorasib +1 More

Targeted Therapy

Recruiting2 awardsPhase 3
"This trial aims to see if a new treatment called sotorasib, along with panitumumab and FOLFIRI, can improve the time before the cancer progresses in patients with metast
Image of The Kirklin Clinic of University of Alabama Birmingham Hospital in Birmingham, United States.

Bevacizumab +2 More

Angiogenesis Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug called onvansertib combined with standard chemotherapy and bevacizumab for colorectal cancer patients with specific gene mutations who didn't respond to earlier treatment. The new drug aims to block cancer cell growth, making the existing chemotherapy work better. Bevacizumab is used in combination with chemotherapy for treating advanced colorectal cancer.
Image of Exelixis Clinical Site #1 in Omaha, United States.

Atezolizumab +2 More

PD-L1 Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a combination of two drugs, XL092 and atezolizumab, against another treatment in patients with a specific type of colorectal cancer that has spread and not responded to standard treatments. The goal is to see if the new combination can better stop cancer growth and help the immune system fight the cancer.
Image of Next Oncology in Fairfax, United States.

CBP-1019

Bi-specific Ligand Conjugated Drug

Recruiting1 awardPhase 1 & 2
This trial is testing CBP-1019, a drug that targets cancer cells, in patients with advanced solid tumors who have no other treatment options. The drug works like a guided missile, finding and attacking cancer cells more precisely.
Image of Alaska Oncology in Anchorage, United States.

Capecitabine +3 More

Anti-metabolites

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of Charles R. Drew University in Los Angeles, United States.

Intervention Group (IG)

Behavioral Intervention

Recruiting1 award8 criteria
This trial observes the impact of a tailored education program on colorectal cancer screening & dietary habits in minority patients w/ type 2 diabetes.
Image of Mid Florida Hematology and Oncology Center in Orange City, United States.

MGC018 +1 More

Antibody-drug conjugate

Recruiting1 awardPhase 2
This trial is testing an experimental drug (MGC018) for mCRPC patients who have had prior ARAT and taxane-containing treatment. 150 participants will be randomized 1:1:1 in Phase 2, and 270 will be randomized 1:1 in Phase 3.
Image of Saint Joseph Heritage Medical Group in Santa Rosa, United States.

Oxaliplatin +5 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing to see if tucatinib in combination with other drugs is more effective than standard of care drugs at treating participants with HER2 positive colorectal cancer.
Image of UCLA - JCCC Clinical Research Unit in Los Angeles, United States.

TORL-3-600

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial will examine the safety and effectiveness of a new cancer drug in patients with advanced cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.